US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 14.9800
- +0.8000+5.64%
Close Sep 4 16:00 ET
1.01BMarket Cap-9024P/E (TTM)
15.0275High14.0400Low454.28KVolume14.1200Open14.1800Pre Close6.72MTurnover1.05%Turnover RatioLossP/E (Static)67.43MShares19.050052wk High2.96P/B649.50MFloat Cap2.050052wk Low--Dividend TTM43.36MShs Float85.0000Historical High--Div YieldTTM6.96%Amplitude0.0300Historical Low14.8010Avg Price1Lot Size
Perspective Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -10.28%-8.9M | 242.43%13.85M | -506.52%-36.91M | -211.59%-9.01M | -610.97%-10.11M | -8.07M | -9.72M | -114.52%-6.09M | -158.59%-2.89M | -128.99%-1.42M |
| Net income from continuing operations | -5.38%-11.7M | -3,211.05%-12.28M | -534.06%-46.51M | -1,087.44%-24.68M | -668.82%-10.36M | ---11.11M | ---371K | -116.56%-7.34M | -95.85%-2.08M | -80.81%-1.35M |
| Operating gains losses | --63K | -90.91%2K | -87.21%39K | --5K | --12K | --0 | --22K | 2,950.00%305K | ---- | ---- |
| Depreciation and amortization | 132.65%570K | 92.22%346K | 585.51%946K | 303.08%262K | 304.69%259K | --245K | --180K | -7.38%138K | 54.76%65K | 77.78%64K |
| Deferred tax | --0 | --0 | ---2.65M | --7.85M | --0 | --0 | ---10.5M | ---- | ---- | ---- |
| Other non cash items | 25.00%-9K | -1,440.00%-268K | 2,414.52%4.31M | 19,122.73%4.23M | 277.78%68K | ---12K | --20K | -358.33%-186K | 4.76%22K | 12.50%18K |
| Change In working capital | 15.26%1.5M | 5,845.70%25.4M | 617.50%2.3M | 287.67%1.98M | -73.25%-544K | --1.3M | ---442K | 577.61%320K | -328.46%-1.05M | -1,156.00%-314K |
| -Change in receivables | 241.43%857K | 16,700.00%166K | -273.88%-426K | -110.90%-58K | -25.35%-618K | --251K | ---1K | 690.32%245K | 8,766.67%532K | -75.44%-493K |
| -Change in inventory | -200.00%-16K | -78.91%27K | 572.37%359K | 105.09%102K | 34.52%113K | --16K | --128K | 72.26%-76K | -1,406.77%-2M | 250.00%84K |
| -Change in prepaid assets | 115.84%61K | -156.67%-154K | -30.52%-325K | -400.89%-337K | 3,908.33%457K | ---385K | ---60K | -344.64%-249K | 11,100.00%112K | 93.41%-12K |
| -Change in payables and accrued expense | -57.74%601K | -419.25%-2.64M | 572.00%2.69M | 642.16%2.27M | -563.55%-496K | --1.42M | ---509K | 72.41%400K | 355.00%306K | -78.34%107K |
| -Change in other working capital | --0 | --28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -10.28%-8.9M | 242.43%13.85M | -506.52%-36.91M | -211.59%-9.01M | -610.97%-10.11M | ---8.07M | ---9.72M | -114.52%-6.09M | -158.59%-2.89M | -128.99%-1.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -475.04%-3.3M | -287.23%-47.3M | 184.51%24.37M | 27.64%-89K | -773.08%-227K | -573K | 25.26M | -6,933.90%-28.84M | 10.87%-123K | 73.74%-26K |
| Net PPE purchase and sale | -82.88%-1.02M | -4,413.43%-9.07M | -609.93%-1.07M | 15.24%-89K | -773.08%-227K | ---555K | ---201K | 60.26%-151K | 8.70%-105K | 71.74%-26K |
| Net business purchase and sale | --0 | --0 | --2.7M | --0 | --0 | --0 | --2.7M | ---- | ---- | ---- |
| Net investment purchase and sale | ---2.28M | -267.92%-38.23M | 200.33%22.76M | --0 | --0 | --0 | --22.76M | ---22.69M | ---- | ---- |
| Net other investing changes | ---- | ---- | 99.70%-18K | --0 | --0 | ---- | ---- | -19,900.00%-6M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -475.04%-3.3M | -287.23%-47.3M | 184.51%24.37M | 27.64%-89K | -773.08%-227K | ---573K | --25.26M | -6,933.90%-28.84M | 10.87%-123K | 73.74%-26K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 23,744.53%122.08M | 208,010.00%166.33M | 2,703.57%785K | 352K | 1K | 512K | -80K | -99.96%28K | 0 | 0 |
| Net issuance payments of debt | 60.00%-8K | 20.00%-12K | ---68K | ---12K | ---21K | ---20K | ---15K | ---- | ---- | ---- |
| Net common stock issuance | 44,103.95%235.17M | --53.27M | 3,178.57%918K | --364K | --22K | --532K | --0 | -99.96%28K | --0 | --0 |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | --10.21M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | 158,353.85%102.87M | ---65K | --0 | --0 | --0 | ---65K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 23,744.53%122.08M | 208,010.00%166.33M | 2,703.57%785K | --352K | --1K | --512K | ---80K | -99.96%28K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 288.43%142.3M | -55.51%9.42M | -62.24%21.18M | -69.26%18.17M | -52.92%28.5M | --36.63M | --21.18M | 2,079.25%56.07M | -9.13%59.09M | 519.78%60.53M |
| Current changes in cash | 1,451.13%109.89M | 759.56%132.88M | 66.32%-11.76M | -190.15%-8.75M | -613.81%-10.34M | ---8.13M | --15.46M | -156.80%-34.9M | -197.53%-3.01M | -102.62%-1.45M |
| End cash Position | 784.83%252.19M | 288.43%142.3M | -55.51%9.42M | -83.20%9.42M | -69.26%18.17M | --28.5M | --36.63M | -66.92%21.18M | -12.40%56.07M | -9.13%59.09M |
| Free cash flow | -14.95%-9.92M | 148.13%4.78M | -509.03%-37.99M | -203.64%-9.1M | -613.88%-10.34M | ---8.63M | ---9.92M | -93.82%-6.24M | -142.98%-3M | -102.80%-1.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg